Clinical efficacy of surgically assisted transjugular intrahepatic portosystemic shunt for cavernous transformation of portal vein

Table 3 Comparison of survival rates, hepatic encephalopathy incidence, gastrointestinal rebleeding incidence and liver failure incidence between the surgically assisted transjugular intrahepatic portosystemic shunt group and control group

	SATIPS group (%)	Control group (%)	P value
Postoperative liver failure
3 months	3.7	9.4	0.26
6 months	3.7	18.9	0.016
Postoperative gastrointestinal rebleeding
3 months	5.6	37.7	< 0.001
6 months	9.3	47.2	< 0.001
Postoperative survival rate
3 months	94.4	92.5	0.72
6 months	94.4	73.6	0.0051
Postoperative hepatic encephalopathy
3 months	3.7	17.0	0.026
6 months	7.4	26.4	0.026

P value < 0.05 suggested that there was significant difference between the two groups. SATIPS: Surgically assisted transjugular intrahepatic portosystemic shunt.